A Novel Modality for Facet Joint Denervation: Cooled Radiofrequency Ablation for Lumbar Facet Syndrome. A Case Series.

Zachary L McCormick, Jeremy Walker, Benjamin Marshall, Robert McCarthy, David R Walega
{"title":"A Novel Modality for Facet Joint Denervation: Cooled Radiofrequency Ablation for Lumbar Facet Syndrome. A Case Series.","authors":"Zachary L McCormick,&nbsp;Jeremy Walker,&nbsp;Benjamin Marshall,&nbsp;Robert McCarthy,&nbsp;David R Walega","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>While cooled radiofrequency ablation (C-RFA) appears to be a promising technology for joint denervation, outcomes of this technique for the treatment of lumbar facet syndrome have not been described. We report clinical outcomes in a case series of patients treated with C-RFA for lumbar facet syndrome.</p><p><strong>Methods: </strong>Consecutive patients aged 18-60 years diagnosed with lumbar facet syndrome, confirmed by ≥75% symptom relief with at least one set of diagnostic medial branch nerve blocks, who underwent C-RFA between January 2007 and December 2013 in an urban academic pain center were included. The respective proportions of participants who reported ≥50% improvement in pain and in function were calculated. Change in median NRS score, daily morphine equivalent consumption (DME), and medication quantification scale III (MQS III) score were measured.</p><p><strong>Results: </strong>Twelve patients underwent C-RFA; three were lost to follow-up. The median and 25%-75% interquartile range (IQR) for age was 44 years (35, 54). The median duration of follow-up was 34 months, IQR (21, 55). The percentage and 95% confidence interval (CI) of patients who reported ≥50% improvement in pain was 33% CI (12%, 64%) and in function was 78%, CI (41%, 96%). There was no significant change in DME or MSQ III score. Approximately 50% of patients sought additional healthcare by long-term follow-up. No complications were reported.</p><p><strong>Conclusions: </strong>This case series suggests that C-RFA may improve function and to a lesser degree pain at long-term follow-up. A randomized, controlled trial is warranted.</p>","PeriodicalId":90945,"journal":{"name":"Physical medicine and rehabilitation international","volume":"1 5","pages":"5"},"PeriodicalIF":0.0000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4389681/pdf/nihms669023.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physical medicine and rehabilitation international","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: While cooled radiofrequency ablation (C-RFA) appears to be a promising technology for joint denervation, outcomes of this technique for the treatment of lumbar facet syndrome have not been described. We report clinical outcomes in a case series of patients treated with C-RFA for lumbar facet syndrome.

Methods: Consecutive patients aged 18-60 years diagnosed with lumbar facet syndrome, confirmed by ≥75% symptom relief with at least one set of diagnostic medial branch nerve blocks, who underwent C-RFA between January 2007 and December 2013 in an urban academic pain center were included. The respective proportions of participants who reported ≥50% improvement in pain and in function were calculated. Change in median NRS score, daily morphine equivalent consumption (DME), and medication quantification scale III (MQS III) score were measured.

Results: Twelve patients underwent C-RFA; three were lost to follow-up. The median and 25%-75% interquartile range (IQR) for age was 44 years (35, 54). The median duration of follow-up was 34 months, IQR (21, 55). The percentage and 95% confidence interval (CI) of patients who reported ≥50% improvement in pain was 33% CI (12%, 64%) and in function was 78%, CI (41%, 96%). There was no significant change in DME or MSQ III score. Approximately 50% of patients sought additional healthcare by long-term follow-up. No complications were reported.

Conclusions: This case series suggests that C-RFA may improve function and to a lesser degree pain at long-term follow-up. A randomized, controlled trial is warranted.

小关节去神经的一种新方式:冷却射频消融治疗腰椎小关节综合征。案例系列。
背景:虽然冷却射频消融(C-RFA)似乎是一种很有前途的关节去神经技术,但该技术治疗腰椎关节突综合征的结果尚未被描述。我们报告了用C-RFA治疗腰椎关节突综合征的一系列病例的临床结果。方法:连续纳入2007年1月至2013年12月在城市学术疼痛中心接受C-RFA治疗的18-60岁腰椎关节突综合征患者,经至少一套诊断性内支神经阻滞证实症状缓解≥75%。分别计算报告疼痛和功能改善≥50%的参与者的比例。测量NRS中位评分、每日吗啡当量消耗量(DME)和用药量化量表III (MQS III)评分的变化。结果:12例患者行C-RFA;3例失访。年龄的中位数和25%-75%四分位数范围(IQR)为44岁(35,54)。中位随访时间为34个月,IQR(21,55)。报告疼痛改善≥50%的患者的百分比和95%置信区间(CI)为33% CI(12%, 64%),功能改善为78% CI(41%, 96%)。DME和MSQ III评分无显著变化。大约50%的患者通过长期随访寻求额外的医疗保健。无并发症报道。结论:本病例系列表明,在长期随访中,C-RFA可以改善功能并减轻疼痛。有必要进行随机对照试验。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信